Publications by authors named "Rei Mimoto"

Claim this Profile
C
Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells.
Rei Mimoto, Satomi Yogosawa, Hiroki Saijo, Atsushi Fushimi, Hiroko Nogi

Sci Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.
Yoshimi Imawari, Rei Mimoto, Shinichi Hirooka, Toshiaki Morikawa, Hiroshi Takeyama

Cancer Sci· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
Hiroko Nogi, Ken Uchida, Rei Mimoto, Makiko Kamio, Hisashi Shioya

Clin Breast Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
Daisuke Ito, Satomi Yogosawa, Rei Mimoto, Shinichi Hirooka, Takashi Horiuchi

Cancer Sci· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.
Rei Mimoto, Naoe T Nihira, Shinichi Hirooka, Hiroshi Takeyama, Kiyotsugu Yoshida

Cancer Lett· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.
Noriko Yamaguchi, Rei Mimoto, Nozomu Yanaihara, Yoshimi Imawari, Shinichi Hirooka

Tumour Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer screening and the changing population pyramid of Japan.
Ken Uchida, Hitoshi Ohashi, Satoki Kinoshita, Hiroko Nogi, Kumiko Kato, Rei Mimoto

Breast Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy.
Rei Mimoto, Tadashi Kobayashi, Yoshimi Imawari, Makiko Kamio, Kumiko Kato

Breast Cancer Res Treat· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
Rei Mimoto, Naoe Taira, Hiroyuki Takahashi, Tomoko Yamaguchi, Masataka Okabe

Cancer Lett· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Individualized treatment of breast cancer chemotherapy].
Rei Mimoto, Tadashi Kobayashi

Nihon Rinsho· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.
Naoe Taira, Rei Mimoto, Morito Kurata, Tomoko Yamaguchi, Masanobu Kitagawa

J Clin Invest· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis